Wockhardt snags Covid-19 vaccine manufacturing deal from the UK govt

This deal by Wockhardt entails only manufacturing the vaccine only for the United Kingdom. The government has reserved one fill and finish production line for its exclusive use for the next 18 months in order to guarantee the supply of vaccines required to fight COVID-19 in the UK, Wockhardt said in a statement.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news